Outline Of New ESMO Guidelines Indicates Inclusion Of FOTIVDA®▼ (Tivozanib) For Patients With Advanced Renal Cell Carcinoma
HEMEL HEMPSTEAD, England--(BUSINESS WIRE/AETOSWire)-- EUSA Pharma (EUSA) welcomes the news that FOTIVDA®▼ (tivozanib) is expected to be included in the ...
